Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma

Samantha Kendrick; Lisa M. Rimsza; David W. Scott; Graham W. Slack; Pedro Farinha; King L. Tan; Daniel Persky; Soham Puvvada; Joseph M. Connors; Laurie Sehn; Randy D. Gascoyne; Monika Schmelz

doi:10.1007/s00428-016-2041-7

Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma

Samantha Kendrick, Lisa M. Rimsza, David W. Scott, Graham W. Slack, Pedro Farinha, King L. Tan, Daniel Persky, Soham Puvvada, Joseph M. Connors, Laurie Sehn, Randy D. Gascoyne, Monika Schmelz

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Original language	English (US)
Pages (from-to)	113-117
Number of pages	5
Journal	Virchows Archiv
Volume	470
Issue number	1
DOIs	https://doi.org/10.1007/s00428-016-2041-7
State	Published - Jan 1 2017

ASJC Scopus subject areas

Pathology and Forensic Medicine
Molecular Biology
Cell Biology

Access to Document

10.1007/s00428-016-2041-7

Cite this

@article{99bb59515f22471084d19916d4d8bbba,

title = "Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma",

author = "Samantha Kendrick and Rimsza, {Lisa M.} and Scott, {David W.} and Slack, {Graham W.} and Pedro Farinha and Tan, {King L.} and Daniel Persky and Soham Puvvada and Connors, {Joseph M.} and Laurie Sehn and Gascoyne, {Randy D.} and Monika Schmelz",

note = "Funding Information: This study was supported by The Hope Foundation/SWOG Development Award (Grant Agreement 2012) and by a Lymphoma Research Foundation Post-Doctoral Fellowship (2558183). We thank the University of Arizona Statistics Consulting Laboratory and Center for Biomedical Informatics and Biostatistics for performing the multivariate survival analysis. ",

year = "2017",

month = jan,

day = "1",

doi = "10.1007/s00428-016-2041-7",

language = "English (US)",

volume = "470",

pages = "113--117",

journal = "Virchows Archiv",

issn = "0945-6317",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "1",

}

TY - JOUR

T1 - Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma

AU - Kendrick, Samantha

AU - Rimsza, Lisa M.

AU - Scott, David W.

AU - Slack, Graham W.

AU - Farinha, Pedro

AU - Tan, King L.

AU - Persky, Daniel

AU - Puvvada, Soham

AU - Connors, Joseph M.

AU - Sehn, Laurie

AU - Gascoyne, Randy D.

AU - Schmelz, Monika

N1 - Funding Information: This study was supported by The Hope Foundation/SWOG Development Award (Grant Agreement 2012) and by a Lymphoma Research Foundation Post-Doctoral Fellowship (2558183). We thank the University of Arizona Statistics Consulting Laboratory and Center for Biomedical Informatics and Biostatistics for performing the multivariate survival analysis.

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.scopus.com/inward/record.url?scp=84997206842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84997206842&partnerID=8YFLogxK

U2 - 10.1007/s00428-016-2041-7

DO - 10.1007/s00428-016-2041-7

M3 - Article

C2 - 27888357

AN - SCOPUS:84997206842

SN - 0945-6317

VL - 470

SP - 113

EP - 117

JO - Virchows Archiv

JF - Virchows Archiv

IS - 1

ER -

Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this